|
No records
|
|
73 |
Kosasih A., Koepfli C., Dahlan M.S., Hawley W.A., Baird J.K., Mueller I., Lobo N.F., Sutanto I. |
56584346800;26536294400;57195937625;7004280510;15921267800;7006910183;35392948100;6603791639; |
Gametocyte carriage of Plasmodium falciparum (pfs25) and Plasmodium vivax (pvs25) during mass screening and treatment in West Timor, Indonesia: a longitudinal prospective study |
2021 |
Malaria Journal |
20 |
1 |
177 |
|
|
|
2 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85104141748&doi=10.1186%2fs12936-021-03709-y&partnerID=40&md5=9c099fec0d8bce6347bf112092d4561b |
PhD Programme in Biomedical Sciences, Medical Faculty, Universitas Indonesia, Jakarta, Indonesia; Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia; Indonesian Medical Education and Research Institute, Jakarta, Indonesia; Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN, United States; PT Epidemiologi Indonesia, Jakarta, Indonesia; UNICEF, Jakarta, Indonesia; Center for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; Infection & Immunity Division, Walter & Eliza Hall Institute, Melbourne, Australia; Department of Parasitology, Medical Faculty, Universitas Indonesia, Jakarta, Indonesia |
Kosasih, A., PhD Programme in Biomedical Sciences, Medical Faculty, Universitas Indonesia, Jakarta, Indonesia, Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia, Indonesian Medical Education and Research Institute, Jakarta, Indonesia; Koepfli, C., Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN, United States, Infection & Immunity Division, Walter & Eliza Hall Institute, Melbourne, Australia; Dahlan, M.S., PT Epidemiologi Indonesia, Jakarta, Indonesia; Hawley, W.A., UNICEF, Jakarta, Indonesia; Baird, J.K., Center for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; Mueller, I., Infection & Immunity Division, Walter & Eliza Hall Institute, Melbourne, Australia; Lobo, N.F., Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN, United States; Sutanto, I., Indonesian Medical Education and Research Institute, Jakarta, Indonesia, Department of Parasitology, Medical Faculty, Universitas Indonesia, Jakarta, Indonesia |
Background: A goal of malaria epidemiological interventions is the detection and treatment of parasite reservoirs in endemic areas—an activity that is expected to reduce local transmission. Since the gametocyte is the only transmissible stage from human host to mosquito vector, this study evaluated the pre and post presence of gametocytes during a mass screening and treatment (MST) intervention conducted during 2013 in East Nusa Tenggara, Indonesia. Methods: RT-qPCR targeting pfs25 and pvs25 transcripts—gametocyte molecular markers for Plasmodium falciparum and Plasmodium vivax, respectively, was performed to detect and quantify gametocytes in blood samples of P. falciparum and P. vivax-infected subjects over the course of the MST study. The presence of both asexual and sexual parasites in microscopic and submicroscopic infections was compared from the start and end of the MST, using proportion tests as well as parametric and non-parametric tests. Results: Parasite prevalence remained unchanged for P. falciparum (6% = 52/811 versus 7% = 50/740, p = 0.838), and decreased slightly for P. vivax (24% = 192/811 versus 19% = 142/740, p = 0.035) between the MST baseline and endpoint. No significant difference was observed in gametocyte prevalence for either P. falciparum (2% = 19/803 versus 3% = 23/729, p = 0.353, OR = 1.34, 95%CI = 0.69–2.63), or P. vivax (7% = 49/744 versus 5% = 39/704, p = 0.442, OR = 0.83, 95%CI = 0.52–1.31). Even though there was an insignificant difference between the two time points, the majority of parasite positive subjects at the endpoint had been negative at baseline (P. falciparum: 66% = 29/44, P. vivax: 60% = 80/134). This was similarly demonstrated for the transmissible stage—where the majority of gametocyte positive subjects at the endpoint were negative at baseline (P. falciparum: 95% = 20/21, P. vivax: 94% = 30/32). These results were independent of treatment provided during MST activities. No difference was demonstrated in parasite and gametocyte density between both time points either in P. falciparum or P. vivax. Conclusion: In this study area, similar prevalence rates of P. falciparum and P. vivax parasites and gametocytes before and after MST, although in different individuals, points to a negligible impact on the parasite reservoir. Treatment administration based on parasite positivity as implemented in the MST should be reevaluated for the elimination strategy in the community. Trial registration Clinical trials registration NCT01878357. Registered 14 June 2013, https://www.clinicaltrials.gov/ct2/show/NCT01878357. © 2021, The Author(s). |
Gametocyte; Mass screening and treatment; Pfs25; Pvs25 |
dihydroartemisinin plus piperaquine; primaquine; adolescent; Article; blood sampling; cell density; controlled study; disease reservoir; endemic disease; female; gametocyte; gene; gene targeting; genetic transcription; human; Indonesia; longitudinal study; major clinical study; malaria falciparum; male; mass screening; microscopy; parasite clearance; parasite transmission; pfs25 gene; Plasmodium vivax malaria; population structure; prevalence; prospective study; pvs25 gene; randomized controlled trial; real time polymerase chain reaction; adult; aged; child; heterozygote; infant; isolation and purification; malaria falciparum; middle aged; parasitology; Plasmodium falciparum; Plasmodium vivax; Plasmodium vivax malaria; preschool child; very elderly; young adult; Adolescent; Adult; Aged; Ag |
BioMed Central Ltd |
14752875 |
|
33836772 |
Article |
Q1 |
1718 |
1764 |
|
|
|
75 |
Lydia A., Setiati S., Soejono C.H., Istanti R., Marsigit J., Azwar M.K. |
8451287200;14325991900;24472241900;23496653300;57218912589;57202798959; |
Prevalence of prehypertension and its risk factors in midlife and late life: Indonesian family life survey 2014–2015 |
2021 |
BMC Public Health |
21 |
1 |
493 |
|
|
|
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102501346&doi=10.1186%2fs12889-021-10544-y&partnerID=40&md5=ca5ddee24de31f31b2409c6356d7d7e6 |
Department of Internal Medicine, Division of Nephrology and Hypertension, Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Clinical Epidemiology and Evidence-Based Medicine, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Department of Internal Medicine, Division of Geriatric Medicine, Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia |
Lydia, A., Department of Internal Medicine, Division of Nephrology and Hypertension, Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Setiati, S., Clinical Epidemiology and Evidence-Based Medicine, Cipto Mangunkusumo Hospital, Jakarta, Indonesia, Department of Internal Medicine, Division of Geriatric Medicine, Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Soejono, C.H., Department of Internal Medicine, Division of Geriatric Medicine, Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Istanti, R., Department of Internal Medicine, Division of Geriatric Medicine, Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Marsigit, J., Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Azwar, M.K., Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia |
Background: Early detection of prehypertension is important to prevent hypertension-related complications, such as cardiovascular disease, cerebrovascular disease and all-cause mortality. Data regarding the prevalence of prehypertension among mid- and late-life population in Indonesia were lacking. It is crucial to obtain the prevalence data and identify the risk factors for prehypertension in Indonesia, which may differ from that of other countries. Methods: The cross-sectional analysis utilized multicenter data from Indonesian Family Life Survey-5 (IFLS-5) from 13 provinces in 2014–2015. We included all subjects at mid-and late-life (aged ≥40 years old) from IFLS-5 with complete blood pressure data and excluded those with prior diagnosis of hypertension. Prehypertension was defined as high-normal blood pressure according to International Society of Hypertension (ISH) 2020 guideline (systolic 130–139 mmHg and/or diastolic 85–89 mmHg). Sociodemographic factors, chronic medical conditions, physical activity, waist circumference and nutritional status were taken into account. Statistical analyses included bivariate and multivariate analyses. Results: There were 5874 subjects included. The prevalence of prehypertension among Indonesian adults aged > 40 years old was 32.5%. Age ≥ 60 years (adjusted OR 1.68, 95% CI 1.41–2.01, p < 0.001), male sex (adjusted OR 1.65, 95% CI 1.45–1.88, p < 0.001), overweight (adjusted OR 1.44, 95% CI 1.22–1.70, p < 0.001), obesity (adjusted OR 1.77, 95% CI 1.48–2.12, p < 0.001), and raised waist circumference (adjusted OR 1.32, 95% CI 1.11–1.56, p = 0.002) were the significant risk factors associated with prehypertension. Prehypertension was inversely associated with being underweight (adjusted OR 0.74, 95% CI 0.59–0.93, p = 0.009). Conclusions: The prevalence of prehypertension in Indonesian mid- and late-life populations is 32.5%. Age ≥ 60 years, male sex, overweight, obesity, and raised waist circumference are risk factors for prehypertension. © 2021, The Author(s). |
Indonesia; Mid- and late-life; Prehypertension; Risk factors |
adult; blood pressure; clinical trial; cross-sectional study; family size; human; hypertension; Indonesia; male; middle aged; multicenter study; prehypertension; prevalence; risk factor; Adult; Blood Pressure; Cross-Sectional Studies; Family Characteristics; Humans; Hypertension; Indonesia; Male; Middle Aged; Prehypertension; Prevalence; Risk Factors |
BioMed Central Ltd |
14712458 |
|
33711980 |
Article |
Q1 |
1230 |
3166 |
|
|
|
76 |
Lazarus G., Findyartini A., Putera A.M., Gamalliel N., Nugraha D., Adli I., Phowira J., Azzahra L., Ariffandi B., Widyahening I.S. |
57214599425;56543777300;57222064804;57222183873;57221389984;57222181089;57221489618;57222184743;57222178259;54893154400; |
Willingness to volunteer and readiness to practice of undergraduate medical students during the COVID-19 pandemic: a cross-sectional survey in Indonesia |
2021 |
BMC Medical Education |
21 |
1 |
138 |
|
|
|
14 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101797052&doi=10.1186%2fs12909-021-02576-0&partnerID=40&md5=fe743e7efa2199d87c6345360ad4e627 |
Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Department of Medical Education, Faculty of Medicine, Universitas Indonesia, Salemba 6, Central, Jakarta, 10430, Indonesia; Medical Education Center, Indonesia Medical Education and Research Institute, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia; Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia |
Lazarus, G., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Findyartini, A., Department of Medical Education, Faculty of Medicine, Universitas Indonesia, Salemba 6, Central, Jakarta, 10430, Indonesia, Medical Education Center, Indonesia Medical Education and Research Institute, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Putera, A.M., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Gamalliel, N., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Nugraha, D., Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia; Adli, I., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Phowira, J., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Azzahra, L., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Ariffandi, B., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Widyahening, I.S., Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia |
Background: The question to involve or restrict medical students’ involvement in the coronavirus disease 2019 (COVID-19) pandemic response remains contentious. As their state of preparation and perceptions in volunteering during this pandemic have yet to be investigated, this study aims to evaluate Indonesian medical students’ willingness to volunteer and readiness to practice during the COVID-19 pandemic. Methods: A web-based survey was conducted among undergraduate medical students throughout Indonesia. Socio-demographic and social interaction information, in addition to willingness to volunteer and readiness to practice, were obtained using a self-reported questionnaire. The significance level was set at 5%. Results: Among 4870 participants, 2374 (48.7%) expressed their willingness to volunteer, while only 906 (18.6%) had adequate readiness to practice. Male students, students with prior volunteering experience in health or non-health sectors, and students from public universities or living in Central Indonesia (vs Java) had higher scores of willingness and readiness to volunteer. Students from Sumatra also had better preparedness (odds ratio [OR] 1.56, 95% confidence interval [CI] 1.15–2.12, p = 0.004), while the opposite occurred for students from Eastern Indonesia (OR 0.63, 95% CI: 0.44–0.89, p = 0.002)–when compared to students from Java. In addition, compared to students with high family income, students from lower-middle income families were less willing to volunteer (OR 0.76, 95% CI: 0.59–0.98, p = 0.034), though those with low family income had better readiness (OR 1.51, 95% CI: 1.10–2.08, p = 0.011). Shortage of medical personnel, sense of duty, and solicitation by stakeholders were the main reasons increasing the students’ willingness to volunteer; whereas contrarily fear for own’s health, absence of a cure, and fear of harming patients were the primary factors diminishing their willingness to volunteer. Conclusion: Our findings indicated that many Indonesian medical students are willing to volunteer, yet only few of them were ready to practice, indicating that further preparations are required to maximize their potentials and minimize their exposure to hazards. We suggest that their potentials as a firm support system during the pandemic should not be overlooked, and that the integration of relevant courses to the medical curricula are imperative to prepare for future public health emergencies. © 2021, The Author(s). |
COVID-19; Indonesia; Medical students; Readiness to practice; Willingness to volunteer |
clinical competence; curriculum; demography; epidemiology; fear; female; human; income; Indonesia; male; medical education; medical student; motivation; pandemic; psychology; self report; sex factor; volunteer; young adult; Clinical Competence; COVID-19; Curriculum; Education, Medical, Undergraduate; Fear; Female; Humans; Income; Indonesia; Male; Motivation; Pandemics; Residence Characteristics; SARS-CoV-2; Self Report; Sex Factors; Students, Medical; Volunteers; Young Adult |
BioMed Central Ltd |
14726920 |
|
33648516 |
Article |
Q1 |
809 |
5954 |
|
|
|
77 |
Findyartini A., Greviana N., Putera A.M., Sutanto R.L., Saki V.Y., Felaza E. |
56543777300;57197709749;57222064804;57222060277;57222061848;57217487889; |
The relationships between resilience and student personal factors in an undergraduate medical program |
2021 |
BMC Medical Education |
21 |
1 |
113 |
|
|
|
2 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101258190&doi=10.1186%2fs12909-021-02547-5&partnerID=40&md5=a9759408209ed0c6e18f2a706196b0ae |
Medical Education Center, Indonesia Medical Education and Research Institute (IMERI), Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Department of Medical Education, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Undergraduate Medical Program, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia |
Findyartini, A., Medical Education Center, Indonesia Medical Education and Research Institute (IMERI), Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Department of Medical Education, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Greviana, N., Medical Education Center, Indonesia Medical Education and Research Institute (IMERI), Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Department of Medical Education, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Putera, A.M., Department of Medical Education, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Undergraduate Medical Program, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Sutanto, R.L., Department of Medical Education, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Undergraduate Medical Program, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Saki, V.Y., Medical Education Center, Indonesia Medical Education and Research Institute (IMERI), Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Felaza, E., Medical Education Center, Indonesia Medical Education and Research Institute (IMERI), Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Department of Medical Education, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia |
Background: Resilience is an essential aspect of wellbeing that plays a major role in undergraduate medical education. Various personal and social factors are known to affect resilience. Empirical evidence remains limited regarding resilience and the personal factors that affect it among undergraduate medical students in an Asian setting. Therefore, this study aims to identify undergraduate medical students’ level of resilience and its relationships to personal factors in Indonesia. Methods: This cross-sectional study was conducted among undergraduate medical students in years 1–6. Respondents were asked to complete three validated questionnaires: the Connor-Davidson Resilience Scale (CD-RISC) to measure resilience, the Brief-COPE to assess coping mechanisms, and the Big Five Personality Test to measure five personality dimensions. Descriptive and Pearson’s correlation analyses were completed to explore relationships between each variable. Regression analysis was completed to analyze the extent to which coping mechanisms, personality, and academic achievement explained the variation in resilience scores. Results: A total of 1040 respondents completed the questionnaires (a 75.42% response rate). Students in both preclinical and clinical stages had quite good levels of resilience and higher scores on adaptive coping mechanisms than on maladaptive coping mechanisms. Adaptive and maladaptive coping mechanisms, Big Five Personality traits (extraversion, agreeableness, conscientiousness, neuroticism, and openness), and students’ academic achievement explained 46.9% of students’ resilience scores. Conclusions: Although the resilience scores in this study were comparable to resilience scores among undergraduate medical students in other settings, we found that coping mechanisms, personality traits, and academic performance may predict resilience among medical students. © 2021, The Author(s). |
Coping mechanism; Medical students; Personality traits; Resilience; Undergraduate |
cross-sectional study; human; Indonesia; medical education; medical student; personality; Cross-Sectional Studies; Education, Medical, Undergraduate; Humans; Indonesia; Personality; Students, Medical |
BioMed Central Ltd |
14726920 |
|
33602176 |
Article |
Q1 |
809 |
5954 |
|
|
|
79 |
Saharman Y.R., Karuniawati A., Severin J.A., Verbrugh H.A. |
55980934300;54886816200;8700385500;7103296623; |
Infections and antimicrobial resistance in intensive care units in lower-middle income countries: a scoping review |
2021 |
Antimicrobial Resistance and Infection Control |
10 |
1 |
22 |
|
|
|
4 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100075262&doi=10.1186%2fs13756-020-00871-x&partnerID=40&md5=137569c4bc3b7584a1b51042515f7130 |
Department of Clinical Microbiology, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, Dr. Molewaterplein 40, Rotterdam, 3015 GD, Netherlands |
Saharman, Y.R., Department of Clinical Microbiology, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia, Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, Dr. Molewaterplein 40, Rotterdam, 3015 GD, Netherlands; Karuniawati, A., Department of Clinical Microbiology, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Severin, J.A., Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, Dr. Molewaterplein 40, Rotterdam, 3015 GD, Netherlands; Verbrugh, H.A., Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, Dr. Molewaterplein 40, Rotterdam, 3015 GD, Netherlands |
Background: Intensive care units (ICUs) in lower-middle income countries (LMICs) are suspected to constitute a special risk for patients of acquiring infection due to multiple antibiotic resistant organisms. The aim of this systematic scoping review was to present the data published on ICU-acquired infections and on antimicrobial resistance observed in ICUs in LMICs over a 13-year period. A systematic scoping review was conducted according to the PRISMA extension guideline for scoping reviews and registered in the Open Science Framework. Main body of the abstract: Articles were sought that reported on ICU-acquired infection in LMICs between 2005 and 2018. Two reviewers parallelly reviewed 1961 titles and abstracts retrieved from five data banks, found 274 eligible and finally included 51. Most LMICs had not produced reports in Q1 or Q2 journals in this period, constituting a large gap in knowledge. However, from the reported evidence it is clear that the rate of ICU-acquired infections was comparable, albeit approximately 10% higher, in LMICs compared to high income countries. In contrast, ICU mortality was much higher in LMICs (33.6%) than in high income countries (< 20%). Multidrug-resistant Gram-negative species, especially Acinetobacter baumannii and Pseudomonas aeruginosa, and Klebsiella pneumoniae played a much more dominant role in LMIC ICUs than in those in high income countries. However, interventions to improve this situation have been shown to be feasible and effective, even cost-effective. Conclusions: Compared to high income countries the burden of ICU-acquired infection is higher in LMICs, as is the level of antimicrobial resistance; the pathogen distribution is also different. However, there is evidence that interventions are feasible and may be quite effective in these settings. Protocol Registration The protocol was registered with Open Science Framework (https://osf.io/c8vjk) © 2021, The Author(s). |
Acinetobacter; Bacterial drug resistance; Cross infection; Infection control; Intensive care units |
antibiotic agent; Acinetobacter baumannii; adult; antibiotic resistance; bacterial infection; cross infection; female; high income country; hospital mortality; human; infection control; intensive care unit; Klebsiella pneumoniae; major clinical study; male; middle income country; multidrug resistance; nonhuman; priority journal; Pseudomonas aeruginosa; Review; bacterial infection; cross infection; developing country; Acinetobacter baumannii; Adult; Bacterial Infections; Cross Infection; Developing Countries; Drug Resistance, Bacterial; Humans; Intensive Care Units; Klebsiella pneumoniae; Pseudomonas aeruginosa |
BioMed Central Ltd |
20472994 |
|
33514432 |
Review |
Q1 |
1456 |
2381 |
|
|
|
No records
|
|
325 |
Gondhowiardjo S.A., Handoko, Tham I., Giselvania A., Bilimagga R.S., Octavianus S., Hiraoka M., Jayalie V.F., Tamaki T., Calaguas M., Nakano T. |
6508327402;57209984822;56736361800;57217201891;16038470700;57217198334;57202560109;57195939736;18538545200;8452403700;35353843800; |
Regional collaboration to improve quality of radiation therapy in Asia |
2021 |
Journal of Medical Imaging and Radiation Oncology |
65 |
4 |
|
424 |
430 |
|
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097537491&doi=10.1111%2f1754-9485.13133&partnerID=40&md5=d4d03b15e65e131d0dbd6e9674b257d4 |
Department of Radiation Oncology, Faculty of Medicine, Universitas Indonesia – Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Radiation Oncology Centre, Mt Elizabeth Novena Hospital, Singapore City, Singapore; Department of Radiation Oncology, HealthCare Global (HCG) Enterprises (Bangalore Institute of Oncology), Bangalore, Karnataka, India; Department of Radiation Oncology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan; Department of Radiation Oncology, Fukushima Medical University, Fukushima, Japan; Division of Radiation Oncology, Department of Radiology, University of the Philippines, Philippine General Hospital, Manila, Philippines; Quantum Medical Science Directorate, National Institute of Radiological Sciences (NIRS), National Institutes for Quantum and Radiological Science and Technology (QST), Chiba, Japan |
Gondhowiardjo, S.A., Department of Radiation Oncology, Faculty of Medicine, Universitas Indonesia – Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Handoko, Department of Radiation Oncology, Faculty of Medicine, Universitas Indonesia – Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Tham, I., Radiation Oncology Centre, Mt Elizabeth Novena Hospital, Singapore City, Singapore; Giselvania, A., Department of Radiation Oncology, Faculty of Medicine, Universitas Indonesia – Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Bilimagga, R.S., Department of Radiation Oncology, HealthCare Global (HCG) Enterprises (Bangalore Institute of Oncology), Bangalore, Karnataka, India; Octavianus, S., Department of Radiation Oncology, Faculty of Medicine, Universitas Indonesia – Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Hiraoka, M., Department of Radiation Oncology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan; Jayalie, V.F., Department of Radiation Oncology, Faculty of Medicine, Universitas Indonesia – Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Tamaki, T., Department of Radiation Oncology, Fukushima Medical University, Fukushima, Japan; Calaguas, M., Division of Radiation Oncology, Department of Radiology, University of the Philippines, Philippine General Hospital, Manila, Philippines; Nakano, T., Quantum Medical Science Directorate, National Institute of Radiological Sciences (NIRS), National Institutes for Quantum and Radiological Science and Technology (QST), Chiba, Japan |
In Asia, several challenges hinder the delivery of high-quality cancer treatment, especially radiation therapy (RT). Many Asian countries face large-scale shortage of RT centres and treatment machines. Additionally, there is also a significant technological gap, with many RT centres in Asia still using outdated technology. There is an urgent need to improve radiation treatment quality in Asia. The Federation of Asian Organizations for Radiation Oncology (FARO) was set up to foster regional collaboration, which we believe can help to identify and solve some of these issues collectively. This report describes the background and rationale of starting FARO, and puts forth some of the early achievements of the group, including fact-finding and educational activities. Finally, we discuss future possibilities, including strategic proposals that may benefit the RT community and our patients in Asia. © 2020 The Royal Australian and New Zealand College of Radiologists |
Asia; cancer; quality; radiation therapy; regional collaboration |
achievement; adult; article; Asia; cancer radiotherapy; human; organization; radiation oncology; radiotherapy; Asia; radiation oncology; Asia; Humans; Radiation Oncology |
Blackwell Publishing |
17549477 |
|
33319494 |
Review |
Q3 |
310 |
14491 |
|
|
|
460 |
Darmaputra D.C., Zaman F.Y., Khu Y.L., Nagalingam V., Liew D., Aung A.K. |
57223041347;57208759841;57208757691;57215386437;7003970080;55117996600; |
Cost-analysis of opportunistic influenza vaccination in general medical inpatients |
2021 |
Internal Medicine Journal |
51 |
4 |
|
591 |
595 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85104572736&doi=10.1111%2fimj.15270&partnerID=40&md5=6be726bbda46f6b4342a09dd962a3b11 |
Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia; Department of General Medicine, The Alfred Hospital, Melbourne, VIC, Australia |
Darmaputra, D.C., Faculty of Medicine, University of Indonesia, Jakarta, Indonesia, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia; Zaman, F.Y., Department of General Medicine, The Alfred Hospital, Melbourne, VIC, Australia; Khu, Y.L., Department of General Medicine, The Alfred Hospital, Melbourne, VIC, Australia; Nagalingam, V., Department of General Medicine, The Alfred Hospital, Melbourne, VIC, Australia; Liew, D., School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia, Department of General Medicine, The Alfred Hospital, Melbourne, VIC, Australia; Aung, A.K., School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia, Department of General Medicine, The Alfred Hospital, Melbourne, VIC, Australia |
Influenza vaccination is an important preventative health measure in the elderly and those with medical comorbidities. It has been shown to reduce hospitalisations, cardiovascular and respiratory complications. A significant proportion of patients admitted to general medicine are eligible for opportunistic inpatient influenza vaccination. This study explores the cost-effectiveness of such a strategy in reducing subsequent healthcare utilisation costs. © 2021 Royal Australasian College of Physicians |
cost-analysis; elderly; influenza; inpatient; vaccination |
aged; article; cost effectiveness analysis; health care utilization; hospital patient; human; influenza vaccination; cost benefit analysis; hospital patient; hospitalization; influenza; vaccination; influenza vaccine; Aged; Cost-Benefit Analysis; Hospitalization; Humans; Influenza Vaccines; Influenza, Human; Inpatients; Vaccination |
Blackwell Publishing |
14440903 |
|
33890379 |
Article |
Q3 |
596 |
8475 |
|
|
|
No records
|
|
546 |
Siste K., Sen L.T. |
55644113100;57219034101; |
Ascending Pattern of Alcohol Use and Underage Drinking in Asia: A Commentary on the Article by Assanangkornchai and Vichitkunakorn (2020) |
2021 |
Alcoholism: Clinical and Experimental Research |
45 |
3 |
|
496 |
499 |
|
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100845814&doi=10.1111%2facer.14556&partnerID=40&md5=c99d4fa613d254d149143468117898a3 |
Department of Psychiatry, Faculty of Medicine, Universitas Indonesia – Cipto Mangunkusumo General Hospital, Jakarta, Indonesia |
Siste, K., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia – Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Sen, L.T., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia – Cipto Mangunkusumo General Hospital, Jakarta, Indonesia |
[No abstract available] |
|
alcohol; adolescent; adulthood; advertising; alcohol consumption; alcohol intoxication; alcohol withdrawal syndrome; alcoholic beverage; alcoholism; brain cortex; brain stem; corpus callosum; cultural factor; depression; drinking behavior; environmental factor; female; gray matter volume; groups by age; hippocampus; human; India; Indonesia; limbic cortex; male; mortality; Note; peer pressure; prefrontal cortex; prevalence; priority journal; psychological resilience; sex difference; social psychology; Southeast Asia; suicide attempt; Thailand; trend study; underage drinking; white matter; World Health Organization |
Blackwell Publishing Ltd |
01456008 |
|
33486766 |
Note |
Q1 |
1267 |
3019 |
|
|
|
554 |
Ross J., Jiamsakul A., Kumarasamy N., Azwa I., Merati T.P., Do C.D., Lee M.P., Ly P.S., Yunihastuti E., Nguyen K.V., Ditangco R., Ng O.T., Choi J.Y., Oka S., Sohn A.H., Law M. |
57193109926;55285745500;7003549856;55553159100;57203678680;56658396600;56143671100;9743902800;57221273925;56370854300;55406840800;57203665233;48761023600;57216171596;7006405275;57222965808; |
Virological failure and HIV drug resistance among adults living with HIV on second-line antiretroviral therapy in the Asia-Pacific |
2021 |
HIV Medicine |
22 |
3 |
|
201 |
211 |
|
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85096661480&doi=10.1111%2fhiv.13006&partnerID=40&md5=9ef6bceb9ed5dc756f178320119cc3c4 |
TREAT Asia/amfAR –The Foundation for AIDS Research, Bangkok, Thailand; The Kirby Institute, UNSW Sydney, Kensington, NSW, Australia; Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), VHS-Infectious Diseases Medical Centre, VHS, Chennai, India; Infectious Diseases Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Faculty of Medicine Udayana University & Sanglah Hospital, Bali, Indonesia; Bach Mai Hospital, Hanoi, Viet Nam; Queen Elizabeth Hospital, Hong Kong; National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia; Faculty of Medicine, Universitas Indonesia - Dr Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; National Hospital for Tropical Diseases, Hanoi, Viet Nam; Research Institute for Tropical Medicine, Muntinlupa City, Philippines; Tan Tock Seng Hospital, Singapore, Singapore; Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea; National Center for Global Health and Medicine, Tokyo, Japan |
Ross, J., TREAT Asia/amfAR –The Foundation for AIDS Research, Bangkok, Thailand; Jiamsakul, A., The Kirby Institute, UNSW Sydney, Kensington, NSW, Australia; Kumarasamy, N., Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), VHS-Infectious Diseases Medical Centre, VHS, Chennai, India; Azwa, I., Infectious Diseases Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Merati, T.P., Faculty of Medicine Udayana University & Sanglah Hospital, Bali, Indonesia; Do, C.D., Bach Mai Hospital, Hanoi, Viet Nam; Lee, M.P., Queen Elizabeth Hospital, Hong Kong; Ly, P.S., National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia; Yunihastuti, E., Faculty of Medicine, Universitas Indonesia - Dr Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Nguyen, K.V., National Hospital for Tropical Diseases, Hanoi, Viet Nam; Ditangco, R., Research Institute for Tropical Medicine, Muntinlupa City, Philippines; Ng, O.T., Tan Tock Seng Hospital, Singapore, Singapore; Choi, J.Y., Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea; Oka, S., National Center for Global Health and Medicine, Tokyo, Japan; Sohn, A.H., TREAT Asia/amfAR –The Foundation for AIDS Research, Bangkok, Thailand; Law, M., The Kirby Institute, UNSW Sydney, Kensington, NSW, Australia |
Objectives: To assess second-line antiretroviral therapy (ART) virological failure and HIV drug resistance-associated mutations (RAMs), in support of third-line regimen planning in Asia. Methods: Adults > 18 years of age on second-line ART for ≥ 6 months were eligible. Cross-sectional data on HIV viral load (VL) and genotypic resistance testing were collected or testing was conducted between July 2015 and May 2017 at 12 Asia-Pacific sites. Virological failure (VF) was defined as VL > 1000 copies/mL with a second VL > 1000 copies/mL within 3–6 months. FASTA files were submitted to Stanford University HIV Drug Resistance Database and RAMs were compared against the IAS-USA 2019 mutations list. VF risk factors were analysed using logistic regression. Results: Of 1378 patients, 74% were male and 70% acquired HIV through heterosexual exposure. At second-line switch, median [interquartile range (IQR)] age was 37 (32–42) years and median (IQR) CD4 count was 103 (43.5–229.5) cells/µL; 93% received regimens with boosted protease inhibitors (PIs). Median duration on second line was 3 years. Among 101 patients (7%) with VF, CD4 count > 200 cells/µL at switch [odds ratio (OR) = 0.36, 95% confidence interval (CI): 0.17–0.77 vs. CD4 ≤ 50) and HIV exposure through male–male sex (OR = 0.32, 95% CI: 0.17–0.64 vs. heterosexual) or injecting drug use (OR = 0.24, 95% CI: 0.12–0.49) were associated with reduced VF. Of 41 (41%) patients with resistance data, 80% had at least one RAM to nonnucleoside reverse transcriptase inhibitors (NNRTIs), 63% to NRTIs, and 35% to PIs. Of those with PI RAMs, 71% had two or more. Conclusions: There were low proportions with VF and significant RAMs in our cohort, reflecting the durability of current second-line regimens. © 2020 British HIV Association |
Asia; drug resistance; HIV; second-line antiretroviral therapy; virological failure |
anti human immunodeficiency virus agent; emtricitabine; Human immunodeficiency virus proteinase inhibitor; integrase inhibitor; lamivudine; lopinavir; nonnucleoside reverse transcriptase inhibitor; raltegravir; RNA directed DNA polymerase inhibitor; tenofovir; adult; antiretroviral therapy; antiviral resistance; Article; Cambodia; CD4 lymphocyte count; cohort analysis; comparative study; cross-sectional study; data base; female; gene mutation; genotyping technique; heterosexuality; Hong Kong; human; Human immunodeficiency virus; Human immunodeficiency virus infected patient; Human immunodeficiency virus infection; India; Indonesia; injection drug user; Japan; major clinical study; Malaysia; male; men who have sex with men; middle aged; Philippines; priority journal; prospective study; retr |
Blackwell Publishing Ltd |
14642662 |
|
33151020 |
Article |
Q1 |
1530 |
2201 |
|
|
|
590 |
Ngoo K.S., Fadzli A.N., Amponin M.O.C.S.E., Cho S.Y., Chuang Y.-C., Horiguchi A., Karthikeyan V.S., Morshed M.S., Situmorang G.R., Tan T.C., Teoh J.Y.-C., Thaidumrong T., Ong T.-A. |
24577210000;56690508000;57221558858;55686246500;16416810000;21634678200;55320137500;57200423093;57190001213;57221554527;55337855700;44062024500;7102866871; |
COVID-19 pandemic impact on urology residencies in Asia - An observational study |
2021 |
Surgical Practice |
25 |
1 |
|
10 |
15 |
|
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099476598&doi=10.1111%2f1744-1633.12474&partnerID=40&md5=2f2654abe61580ca20505968f145337d |
Department of Surgery, Hospital Angkatan Tentera Tuanku Mizan, Kuala Lumpur, Malaysia; Urology Unit, Department of Surgery, University of Malaya Medical Center, Kuala Lumpur, Malaysia; Department of Surgery, Our Lady of Lourdes Hospital, Manila, Philippines; Department of Urology, Seoul National University Hospital, Seoul, South Korea; Department of Urology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Department of Urology, National Defense Medical College, Saitama, Japan; Men's Health and Urology, Sri Narayani Hospital and Research Centre, Vellore, India; Department of Urology, Dhaka Medical College Hospital, Dhaka, Bangladesh; Department of Urology, Cipto Mangunkusumo National Referral Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Urology C Department, Binh Dan Hospital, Ho Chi Minh City, Viet Nam; Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong; Division of Urology, Department of Surgery, Rajavithi Hospital, Bangkok, Thailand |
Ngoo, K.S., Department of Surgery, Hospital Angkatan Tentera Tuanku Mizan, Kuala Lumpur, Malaysia; Fadzli, A.N., Urology Unit, Department of Surgery, University of Malaya Medical Center, Kuala Lumpur, Malaysia; Amponin, M.O.C.S.E., Department of Surgery, Our Lady of Lourdes Hospital, Manila, Philippines; Cho, S.Y., Department of Urology, Seoul National University Hospital, Seoul, South Korea; Chuang, Y.-C., Department of Urology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Horiguchi, A., Department of Urology, National Defense Medical College, Saitama, Japan; Karthikeyan, V.S., Men's Health and Urology, Sri Narayani Hospital and Research Centre, Vellore, India; Morshed, M.S., Department of Urology, Dhaka Medical College Hospital, Dhaka, Bangladesh; Situmorang, G.R., Department of Urology, Cipto Mangunkusumo National Referral Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Tan, T.C., Urology C Department, Binh Dan Hospital, Ho Chi Minh City, Viet Nam; Teoh, J.Y.-C., Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong; Thaidumrong, T., Division of Urology, Department of Surgery, Rajavithi Hospital, Bangkok, Thailand; Ong, T.-A., Urology Unit, Department of Surgery, University of Malaya Medical Center, Kuala Lumpur, Malaysia |
Objective: The Coronavirus Disease 2019 (Covid-19) pandemic affected surgical training in many ways. This observational study was carried out to evaluate the impact of Covid-19 on urological residencies across Asia. Methodology: An open-ended survey questionnaire examining key areas in a urology training program was distributed to several urologists in Asia. The survey evaluated seven areas including the burden of Covid-19 disease, the need for re-deployment of residents, the impact on clinical work, the effect on research work for residents, the delivery of teaching to the residents, the impact on training and assessments, the effects on mental, personal health and social welfare of residents. Results: Reports from 11 Asian countries were analysed. There is stark variability in Covid-19 disease burden across Asia. Re-deployment occurred in selected Asian countries. Affected residents reported challenges obtaining personal protective equipment and training. Clinical workload and research were generally reduced except for countries reporting low volume Covid-19 cases. Residents teaching evolved from in-person to online platforms. Almost all residency program postponed their examinations. Mental health disturbance was more pronounced than personal health. Conclusions: The Covid-19 pandemic presented multiple obstacles to Asian urology residencies. The understanding of these challenges will assist program directors in developing mitigating measures. © 2020 College of Surgeons of Hong Kong |
Covid-19; pandemic; residency; urology |
anxiety; Article; coronavirus disease 2019; health; human; human experiment; learning; medical practice; medical student; mental health; multicenter study; observational study; propensity score; prostate biopsy; questionnaire; residency education; resuscitation; social status; social welfare; surgical training; teaching; teleconsultation; transrectal ultrasonography; urodynamics; uroflowmetry; urologist; urology; workload |
Blackwell Publishing Ltd |
17441625 |
|
|
Article |
Q4 |
109 |
28907 |
|
|
